Recent studies have suggested that EBV LMP1 may mediate energy metabolism reprogramming in EBV-infected cancer cells, including alterations in aerobic glycolysis, by activating the expression of specific metabolic enzymes, such as hexokinase 2 (HK2) [10–12]. This evidence concerns the gene PDLIM7 and cancer.